Keloid Scarring: New Treatments Ahead

被引：28

作者：

Mrowietz, Ulrich ^{[1
]}

Seifert, Oliver ^{[2
]}

机构：

[1] Univ Med Ctr Schleswig Holstein, Dept Dermatol, Campus Kiel Schittenhelmstr 7, D-24105 Kiel, Germany

[2] Cty Hosp Ryhov, Dept Dermatol, Jonkoping, Sweden

来源：

ACTAS DERMO-SIFILIOGRAFICAS | 2009年 / 100卷

关键词：

keloid; treatment; physiopathology; molecular mechanisms; TGF-beta; 3; interleukin; 10; imatinib mesylate;

D O I：

10.1016/S0001-7310(09)73382-4

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 [皮肤病与性病学];

摘要：

Keloid disease presents a healthcare challenge: patients suffer from pruritus, pain, inflammation, and cosmetic disfigurement. There is no single effective therapeutic regimen for keloids. Numerous treatment options have been described including occlusive dressings, compression therapy, intralesional steroid injections, laser and radiation therapy, cryosurgery, 5-fluorouracil, interferon, and imiquimod cream, but managing keloid disease still is a considerable problem for clinicians. Better understanding of the molecular mechanisms behind keloid disease led to the development of new promising therapies like the application of recombinant TGF-beta 3, interleukin 10, and imatinib mesylate. This review provides an overview of the existing therapeutic options for keloid disease and summarizes upcoming future therapies with a special focus on blocking the transforming growth factor-beta pathway.

引用

页码：75 / 83

页数：9

共 81 条

[1]

ALIBERT JLM, 1806, DESCRIPTION MALADIES, P113

[2]

Failure of interferon-alpha 2B in the treatment of mature keloids [J].

AlKhawajah, MM .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 1996, 35 (07) :515-517

[3]

TREATMENT OF KELOID STERNOTOMY SCARS WITH 585 NM FLASHLAMP-PUMPED PULSED-DYE LASER [J].

ALSTER, TS ;

WILLIAMS, CM .

LANCET, 1995, 345 (8959) :1198-1200

[4]

Description of site-specific morphology of keloid phenotypes in an Afrocaribbean population [J].

Bayat, A ;

Arscott, G ;

Ollier, WER ;

Ferguson, MWJ ;

Mc Grouther, DA .

BRITISH JOURNAL OF PLASTIC SURGERY, 2004, 57 (02) :122-133

[5]

Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids [J].

Berman, B ;

Kaufman, J .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) :S209-S211

[6]

SHORT-TERM KELOID TREATMENT INVIVO WITH HUMAN INTERFERON-ALFA-2B RESULTS IN A SELECTIVE AND PERSISTENT NORMALIZATION OF KELOIDAL FIBROBLAST COLLAGEN, GLYCOSAMINOGLYCAN, AND COLLAGENASE PRODUCTION INVITRO [J].

BERMAN, B ;

DUNCAN, MR .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (04) :694-702

[7]

A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management [J].

Berman, Brian ;

Perez, Oliver A. ;

Konda, Sailesh ;

Kohut, Bruce E. ;

Viera, Martha H. ;

Delgado, Suzette ;

Zell, Deborah ;

Li, Qing ;

Gold, Michael H. .

DERMATOLOGIC SURGERY, 2007, 33 (11) :1291-1303

[8]

Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].

Blobe, GC ;

Schiemann, WP ;

Lodish, HF .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358

[9]

BLOOM D., 1956, NEW YORK STATE JOUR MED, V56, P511

[10]

BLUMENKRANZ M, 1984, OPHTHALMOLOGY, V91, P122

← 1 2 3 4 5 6 7 8 9 →